The stage-specific regulation of milk protein gene expression is controlled by the lactogenic hormones glucocorticoids and prolactin. Both hormones have been documented to synergistically induce the expression of these genes at the level of transcription initiation (1) . Lactogenic hormone response elements have been defined in the promoter region and upstream enhancer regions of the genes encoding the milk proteins ␣S1-casein (2), ␤-casein (1, 3, 4) , whey acidic protein (5-7), and ␤-lactoglobulin (8) . They all contain binding sites for the prolactin inducible transcription factor MGF/Stat5 1 (2, 8 -10) . A mutation introduced into the Stat5-binding site has been shown to destroy the response of the promoter not only to prolactin but also to glucocorticoids (11) , indicating that Stat5 is necessary for mediating the effects of prolactin and glucocorticoids. Glucocorticoids do not significantly change the binding activity of MGF/Stat5 to lactogenic hormone response elements (12) , ruling out the possibility that they act synergistically with prolactin simply by enhancing the effect of prolactin on the activation of Stat5 DNA binding.
In vitro binding studies with purified preparations of the glucocorticoid receptor revealed the presence of multiple GRbinding sites in the lactogenic response elements of the rat ␤-casein gene promoter (13) , the proximal mouse whey acidic protein gene promoter (13) , and the distal rat whey acidic protein gene promoter (14) . Interestingly, only sequence motifs resembling half-palindromic GR-binding sites were contained within the footprinted regions. Transactivation mediated by the glucocorticoid receptor usually requires the binding of dimeric receptor molecules to palindromic DNA-binding sites (15) (16) (17) , whereas half-sites binding monomeric GR complexes have been reported to be insufficient by themselves to confer hormone responsiveness (17) . However, monomeric GR molecules binding to receptor half-palindromic sites were proposed to gain competence as transcriptional activators by interacting with other transcription factors (18) .
We tested whether GR molecules binding to half-palindromic sites in the rat ␤-casein gene promoter can functionally interact with MGF/Stat5 in the activation of milk protein gene transcription. COS-7 cells were employed in transient co-transfection assays using wild-type and mutated ␤-casein gene promoter CAT constructs. These cells allow the reconstitution of prolactin-dependent signaling cascades by transfection of prolactin receptor and Stat5 expression vectors (19) . They also can be used to study the synergy between Stat5 and GR in cotransfection experiments (20) . The results presented here suggest that GR half-palindromic sites serve to recruit GR molecules to the ␤-casein gene promoter and are instrumental for mediating the synergistic effect between glucocorticoids and prolactin. Experiments with stably transfected HC11 mammary epithelial cells, which do not overexpress Stat5 and GR molecules, lead to the same conclusion. Efficient transactivation by GR molecules was dependent on the activation and binding of Stat5 to its recognition site. Interestingly, transactivation was also possible with Stat5 molecules devoid of their carboxylterminal transactivation domain.
MATERIALS AND METHODS
Plasmids-␤-Casein gene promoter constructs with mutations in the glucocorticoid receptor half-sites were prepared by site-directed mutagenesis using the protocol of Deng and Nickoloff (21) . The ␤-casein CAT promoter gene p␤c(Ϫ344/Ϫ1)CAT was used as a template (22) . The selection primer for introducing the first mutation was 5Ј-CCCCGGG-TACAGATCTCGAATTCGT-3Ј. It destroys the unique SacI and KpnI cutting sites, replacing them with a BglII site. For a second round of mutation, the primer 5Ј-GGATCGATCCTCGAGTACAGATCT-3Ј was used. It destroys the unique SmaI site and creates a novel XhoI site. The primers used for introducing mutations into the GR sites (in parentheses) were: 5Ј-CCTTGTTTAAGCTTCCCCAGAATT-3Ј (mGRc), 5Ј-TTTCTAATCAAGCTTACTTCTTGGA-3Ј (mGRd), 5ЈTTGGAATTAAC-AGACTTTTGAA3Ј (mGRe), and 5Ј-TTTCTAATCAAGCTTACTTCTTG-GAATTAACAGACTTTTGAA-3Ј (mGRd and mGRe). For mutations in the GR sites of footprints a and b the Quick Change site-directed mutagenesis protocol of Stratagene was used. The upper strands of the oligonucleotides employed were: 5Ј-GGCTGGGGAGAATTCTGATGAC-TGTTTACTAGGCTGGAG-3Ј (mGRa); 5Ј-GGCTGGAGAGAATTCCAG-TTATTTGACAATTTCCTTTCC-3Ј (mGRa/b); 5Ј-CAATTTCCTTTCCT-TGACGAATTCCTTCACCAGCTTCTG-3Ј (mGRb). The construct with the mutation of the MGF/Stat5 site and the heterologous ␤-casein gene thymidine kinase (tk) promoter CAT constructs employed have been described (23) . The construct pMMTV-CAT was prepared by inserting a 1.3-kilobase pair PstI/BamHI fragment, spanning the region from Ϫ1187 to ϩ102 of the mouse mammary tumor virus-long terminal repeat, into the 5Ј polylinker of pBLCAT3 (24) . The constitutively active luciferase expression vector pAGLuE5, driven by the SV40 early promoter, was provided by Dr. T. Schlake. Stat5 expression vectors were constructed by insertion of Stat5a and Stat5b cDNA cloned from a mouse mammary gland ZAP library 2 into pECE (25) . The carboxylterminally deleted forms of Stat5a and Stat5b were prepared by introducing a stop codon at amino acid 738 position of Stat5a and the corresponding position (amino acid 742) of Stat5b. The rat glucocorticoid expression vector PSTC GR 3-795 (26) contains the cDNA of the rat glucocorticoid receptor encoding amino acids 3-795.
Cell Culture and Hormone Inductions-COS-7 cells were propagated in Dulbecco's modified Eagle's medium containing 10% heat-inactivated fetal calf serum, and 50 g/ml gentamycin. HC11 cells were grown in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum, 5 g/ml insulin, 10 ng/ml epidermal growth factor, and 50 g/ml gentamycin. Prior to hormone treatment, HC11 cells were kept for 2 days in epidermal growth factor-free medium containing 2% fetal calf serum as described (23) . Hormone inductions were performed with 5 g/ml ovine prolactin (31 units/mg, Sigma) and 0.1 M dexamethasone (Sigma), as indicated.
Electromobility Shift Assays-Experimental procedures were as described previously (23) . Double-stranded oligonucleotides labeled with [␥-32 P]ATP (Ͼ6000 Ci/mmol) and annealed to the complementary oligonucleotides as described (23) were used. The sequence of the upper strand of the oligonucleotides employed was: SIE, 5Ј-GTGCATTTC-CCGTAAATCTTGTCTACAATTC-3Ј; PRE, 5Ј-AGCTTAGAACACAGT-GTTCTCTAGAC-3Ј; GRc, 5Ј-GCTGCCTTGTTTAATGTCCCCCAGAA-TTTCTTGG-3Ј; mGRc, 5Ј-GCTGCCTTGTTTAAGCTTCCCCAGAATT-TCTTGG-3Ј; GRdϩe, 5Ј-CTAATCATGTGGACTTCTTGGAATTAAGG-GACTTTTG-3Ј. Electromobility shift assays were performed on a 4% polyacrylamide gel in 0.25 ϫ TBE electrophoresis buffer. Binding reactions were as described (27) . GR-DBD expressed in Escherichia coli was purified as described (28) and used for binding reactions in a buffer containing 10 mM Hepes, pH 7.5, 2.5 mM MgCl 2 , 10% glycerol (w/v), 50 mM KCl, 0.1 mM EDTA, 1 mM dithiothreitol, 50 ng of poly(dI-dC).
Cell Transfection and CAT Assay-Transfections with the calcium phosphate precipitation technique, selection and propagation of stably transfected HC11 cells, and CAT assays were performed as described (27) . Transient transfection of COS-7 cells were made with cultures plated on 6-well dishes. The total amount of cotransfected DNA was 20 g/6 wells. For preparing extracts to determine CAT and luciferase activity, COS-7 cells were washed with ice-cold phosphate-buffered saline, incubated for 5 min with 1 ml of buffer containing 40 mM Tris-HCl, pH 7.5, 1 mM EDTA, 150 mM NaCl, and harvested by scraping them off the dish with a rubber policeman. The subsequent steps were performed at 0 -4°C. Two aliquots of 450 l each of the resuspended cells were transferred to a microcentrifuge tube, centrifuged for 5 min at 1000 ϫ g, and the supernatants were removed by aspiration. One of the aliquots was used for determination of CAT activity (27) . A luciferase assay was performed with the other aliquot as described (29) .
RESULTS

Reconstitution of Promoter-dependent Synergy between the Glucocorticoid Receptor and Stat5 in COS-7
Cells-A regulatory region in the ␤-casein gene promoter required for the synergistic action of glucocorticoid hormones and prolactin was mapped in HC11 mammary epithelial cells (1, 23) . It comprises the MGF/Stat5 site and a region located 5Ј to this site. We have investigated the role of this 5Ј region in mediating the synergy between glucocorticoids and prolactin in COS-7 cells. These cells were shown to be a suitable system to study the prolactindependent transactivation activity of Stat5 (19) . Cotransfections were performed with expression plasmids for mouse Stat5a, mouse prolactin receptor, and a ␤-casein (Ϫ344/Ϫ1) promoter CAT reporter gene. Increasing amounts of a glucocorticoid receptor expression plasmid were included. The cotransfected cells were stimulated with dexamethasone or prolactin or a combination of both. In the absence of cotransfected glucocorticoid receptors (Fig. 1 , first 4 columns) dexamethasone did not have a significant effect on transcription. The synergism between dexamethasone and prolactin increased in a concentration dependent fashion by cotransfection of GR expression vector (Fig. 1 ). Using 40 -1000 ng of GR expression vector the synergistic effect approached the level observed in HC11 cells for the regulation of a stably transfected ␤-casein (Ϫ344/Ϫ1) gene promoter CAT construct (23) . Further cotransfection studies were performed with 200 ng of GR expression vector.
We next investigated whether the MGF/Stat5 site alone is sufficient to mediate the synergistic response in COS-7 cells. A 30-base pair region comprising the MGF/Stat5 site in the ␤-casein gene promoter or a region extending from Ϫ344 to Ϫ82 cloned in front of a thymidine kinase-CAT reporter gene were analyzed. The short fragment with the MGF/Stat5 site only conferred a transcriptional response upon prolactin stimulation to the thymidine kinase-CAT reporter (Fig. 2) . However, no synergism was observed with dexamethasone. By contrast, 2 T. Welte, unpublished data. a marked increase in transcriptional activation was obtained upon stimulation with dexamethasone and prolactin, when the ␤-casein gene promoter fragment (Ϫ344/Ϫ82) was used. The synergistic transcriptional activation mediated by prolactin and dexamethasone is hence dependent on sequences 5Ј to the MGF/Stat5 site in COS-7 cells as has been found previously in HC11 cells (23) .
Glucocorticoid Receptor Half-palindromic Sites in the ␤-Casein Gene Promoter-In a previous study GR-binding sites were mapped in the rat ␤-casein gene promoter by in vitro footprint analysis using purified rat liver glucocorticoid receptor (13) . Five regions were identified to be protected from digestion by DNase I (Fig. 3, footprints a-e) . They contain sequence motifs related to half-sites of classical glucocorticoid response elements. The functionality of the putative half-site contained in footprint c to bind the GR was investigated by electromobility shift assays employing the DNA-binding domain of the glucocorticoid receptor (GR-DBD, Fig. 4A ). The oligonucleotide GRc, spanning the footprinted region c of the ␤-casein gene promoter and a corresponding oligonucleotide harboring a mutation in the putative half-site (mGRc, mutation as shown in Fig. 3 ) were used as DNA probes. A classical palindromic GRbinding site (PRE) and a sequence devoid of described GRbinding sites (SIE) served as controls. Very weak binding was observed with the SIE (Fig. 4A, lanes 1 and 2) . With a palindromic GRE (PRE oligo) two retarded bands were detected (Fig.  4A, lanes 3 and 4) . The two bands represent complexes containing receptor monomers or dimers. This is in accordance with previous reports (18, 30) . With the GRc probe, formation of a complex migrating at the position of receptor monomers was observed (Fig. 4A, lanes 5 and 6) . Binding activity of the mutated GRc probe was reduced to the low level observed with to the SIE probe (Fig. 4A, compare lanes 1 and 2 with 7 and 8) . The experiment confirms the assumption that the integrity of the half-palindromic site in the GRc probe is required for the binding of the GR. In electromobility shift assays with a DNA probe comprising the half-sites in GRd and GRe (GRdϩe), formation of complexes with two receptor molecules was observed at high concentrations of GR-DBD (Fig. 4B, lanes 1 and  2) . Electromobility shift assays performed with oligonucleotides with targeted mutations in either Grd or GRe palindromic half-sites revealed that the integrity of the half-sites in GRd and GRe is important for the formation of these complexes (data not shown). In comparison to the PRE probe with the palindromic GR site (Fig. 4B, lanes 5-7) , formation of complexes containing two receptor molecules required significantly higher concentration of the GR-DBD (Fig. 4B, compare lanes 1  and 2 to lanes 5 and 6) , indicating that the configuration of the two binding sites in GRdϩe does not favor co-operative binding of GR molecules to the same extent as the classical palindromic site in PRE.
Glucocorticoid Receptor-binding Sites Are Required for Promoter Function-To determine the importance of the GR sites for promoter function, mutations affecting the various GR halfsite were introduced into the ␤-casein (Ϫ344/Ϫ1)CAT plasmid. The mutations employed are shown in Fig. 3 on top of the sequence. Cotransfections with the mutated promoter constructs were performed in COS-7 cells as described above. The ability of dexamethasone to augment the response of prolactin was quantified by determining the ratio of the CAT activity in cells stimulated with dexamethasone and prolactin versus the activity in cells treated with prolactin only (Fig. 5A) . Mutations in GR half-sites a, b, c, and e led to a reduction of the ratio to 17 (mGRa), 29 (mGRa/b), 30 (mGRb), 34 (mGRc), and 42% (mGRe) of the wild-type ␤-casein CAT construct. The induction ratio was almost completely abolished in constructs harboring double mutations of GRc and GRe (Fig. 5A , mutations mGRcϩe and mGRcϩdϩe), indicating a co-operation of these binding (24); (Ϫ104/Ϫ75)tk, heterologous promoter construct containing the region between Ϫ104 and Ϫ75 of the rat ␤-casein gene promoter in front of the thymidine kinase promoter. (Ϫ344/Ϫ82)tk, contains the region between Ϫ344 and Ϫ82 of the rat ␤-casein gene promoter. Relative CAT activities were measured as described in the legend to Fig. 1.   FIG. 3 . GR-binding sites in the lactogenic hormone response element of the rat ␤-casein gene promoter. The sequence between Ϫ300 and Ϫ61 of the rat ␤-casein gene promoter together with the localization of the footprints a-e, mapped previously by DNase I footprinting with the rat liver GR (13), is shown. Potential hexameric GR half-sites are represented by boxes with arrows indicating their orientation compared with a palindromic site. They all contain a G in the second position, a T in the third position, and a C in the fifth position which have been shown to be of crucial importance for binding (52) . The mutations mGRa, mGRa/b, mGRb, mGRc, mGRd, and mGRe introduced into the half-sites of footprints a-e are shown on top of the sequence. The position of the major MGF/Stat5-binding site is depicted by an ellipsis.
sites for mediating the synergism of GR with Stat5. The effect of a mutation in GRd was not statistically significant. This mutation also had no significant additional effect when combined with mutations of either GRc or GRe or both (Fig. 5A , mutations mGRd, mGRcϩd, mGRdϩe, and mGRcϩdϩe).
As shown in the upper panel of Fig. 5B for COS-7 cells, the activation of transcription by prolactin alone was not altered by the triple GR mutation, indicating that the effect is selective on the action of glucocorticoids. Mutation of the MGF/Stat5 site, however, strongly interfered with the prolactin response. In this mutant the synergistic effect of dexamethasone was also reduced. The weak but significant induction observed is most probably explained by an incomplete inhibition of Stat5 binding by the mutation. The data presented document the functional importance of the GR half-sites in GRa, GRb, GRc, and GRe for GR action. Furthermore, they show the dependence of GR on co-operation with Stat5, which also has to bind to the promoter.
To examine whether the findings obtained in Stat5 and GR overexpressing COS-7 cells are also relevant for the situation in mouse mammary epithelial cells expressing physiological levels of these two transcription factors, HC11 cells were stably transfected with the same mutated reporter constructs (Fig.  5B, lower panel) . The results obtained in HC11 cells supported the conclusions drawn from the experiments with the COS-7 cell system. The triple mutation affecting the three GR-binding sites c, d, and e strongly reduced the synergistic activation of the ␤-casein promoter by dexamethasone and prolactin. Destroying the Stat5-binding site also inhibited prolactin-and dexamethasone-induced transactivation.
To determine whether the GR sites in GRc and GRe are sufficient for mediating the synergism with Stat5, constructs were prepared with 5Ј deletions of the ␤-casein promoter placed in front of a minimal thymidine kinase promoter and analyzed in COS-7 cotransfection experiments (Fig. 5C) . A (Ϫ176/Ϫ82)␤-casein thymidine kinase promoter which harbors the GRc-and GRe-binding sites failed to confer the prolactin and dexamethasonedependent synergistic transactivation. The responsiveness to dexamethasone and prolactin was restored in the constructs which contain the regions GRa and GRb (Fig. 5C , p␤c(Ϫ344/ Ϫ82)thymidine kinase-CAT and p␤c(Ϫ282/Ϫ82)thymidine kinase-CAT)). Thus, the distal ␤-casein gene promoter region with the GR-binding sites for GRa and GRb is necessary for mediating the synergism between GR and Stat5. As shown above (Fig. 5A) , the functionality of this region is dependent on the integrity of the proximal GR-binding sites in GRc and GRe, implying that the synergism depends on a co-operation of distal and proximal sites.
The Carboxyl-terminal Transactivation Domain of Stat5 Is Not Required for the Synergism with the Glucocorticoid Receptor-The two highly related Stat5 molecules Stat5a and Stat5b are expressed in the mammary epithelium. We wanted to examine whether they behave similarly in synergizing with the GR. Cotransfection experiments in COS-7 cells were performed as above. As shown in Fig. 6 , no significant differences were observed in transactivation of the ␤-casein gene promoter upon induction with dexamethasone and prolactin. We also tested carboxyl-terminally deleted forms of Stat5a and Stat5b, lacking the region with the major transcriptional activation domain (31) . Surprisingly, the deleted forms were as efficient as the full-length Stat5 isoforms in their synergy with the GR. Thus, the transactivation domain in the carboxyl-terminal region of Stat5 is not required for the establishment of the synergism with the glucocorticoid receptor.
DISCUSSION
The steroid receptor superfamily and Stat molecules represent two archetypal families of signaling molecules which evolved to meet the requirement of cells to respond differentially to diverse extracellular stimuli. The specificity of the response is controlled at two levels (15, 32) Integration of different signaling pathways is a further means to increase the versatility of the response to extracellular stimuli (33) (34) (35) . In this study we have investigated how integration of the signaling pathways triggered by the two 1 and 2) ; PRE ( lanes 3 and 4) ; GRc, oligonucleotide spanning footprint c ( lanes 5 and 6) ; mGRC, mutated GRc (lanes 7 and 8, mutation as depicted in Fig. 3). 2 l (lanes 1, 3, 5, and 7) and 1 l (lanes 2,  4, 6 , and 8) of GR-DBD were used. B, footprinted regions d and e: GRdϩe, oligonucleotide spanning GR half-sites GRd and GRe ( lanes  1-4); PRE (lanes 5-8) . 300 ng (lanes 1 and 5), 150 ng (lanes 2 and 6) , 75 ng (lanes 3 and 7) , or no GR-DBD (lanes 4 and 8) were used.
pleiotropic hormones prolactin and glucocorticoids leads to the specific activation of milk protein gene transcription.
When this article was in preparation, Stöcklin et al. (20) reported a direct interaction between Stat5 and the GR overexpressed in COS-7 cells. A model was proposed where the GR acts as a co-activator of Stat5 in a mode which is independent of a GRE. The results presented in our study do not support this model, since they provide clear evidence that GR and Stat5 molecules, activated by the two hormones, interact in a lactogenic hormone response element dependent fashion. DNAbinding sites for both the GR and Stat5 were demonstrated to be essential in mediating their synergism on ␤-casein gene induction. However, protein-protein interactions between GR and Stat5, as the one observed by Stöcklin et al. (20) , might also FIG. 5 . Effect of mutations introduced into GR and MGF/Stat5-binding sites of the ␤-casein gene promoter on the synergism between glucocorticoids and prolactin. A, effect of GR half-site mutations on the synergistic effect of dexamethasone in COS-7. Cells were transiently cotransfected with the wild-type (Ϫ344/Ϫ1)CAT reporter construct (w.t.) or mutated versions as specified at the bottom of the columns together with expression vectors for Stat5a, prolactin receptor, glucocorticoid receptor, and luciferase as described in the legend to Fig. 2 . The CAT activity was measured in extracts treated for 24 h either with dexamethasone and prolactin, or only with prolactin, and normalized to luciferase activity. The ratio of the activity in dexamethasone and prolactin-treated cells versus the activity in prolactin-treated cells was calculated. Bars show the mean ratio Ϯ S.E. of three experiments, each performed with at least duplicate inductions. B, effect of the triple GR site mutation and the MGF/Stat5 mutation on transactivation in COS-7 (top panel) and HC11 cells (bottom panel). Transient co-transfection experiments and hormone inductions of COS-7 cells were performed as described in the legend to Fig. 2 . HC11 cells were stably transfected with the specified constructs and CAT activity was determined in extracts of confluent HC11 cells treated with dexamethasone (0.1 M) and prolactin (5 g/ml) for 4 days (ϩ Dex/PRL), or of cells without hormones (ϪDex/PRL). CAT activity is shown relative to hormone treated wild-type promoter constructs. Results are expressed as mean Ϯ S.E. of at least three independent determinations. C, role of the ␤-casein gene promoter region between Ϫ344 and Ϫ170 on mediating the synergy between glucocorticoid and prolactin. The indicated constructs were transiently cotransfected into COS-7 cells and lactogenic hormone regulated expression was analyzed as described in the legend to Fig. 2 . Results are expressed as mean Ϯ S.E. of three independent determinations. be important for a productive functional interaction of GR and Stat5 molecules, recruited to the lactogenic hormone response elements of milk protein gene promoters. In fact, a role for both DNA-template dependent and independent interactions of the GR or Stat5 with other transcription factors has been demonstrated frequently. GR homodimers bound to palindromic GR consensus sites were described to interact with several unrelated transcription factors bound to vicinal sites (15, 33, 36) . In addition, direct DNA-template independent interactions of the GR with the transcription factors NFB (37), NF-IL6 (38) , and AP-1 (reviewed in Ref. 39 ) have been reported. Protein-protein interactions of GR monomers and AP-1 were suggested to be involved in the repression of transcription factor AP-1 activity (40) . Interactions involving both DNA binding and proteinprotein contacts are the hallmark of composite glucocorticoid response elements (41) , which mediate a positive or negative effect of glucocorticoids on transcription depending on the type of the cooperating transcription factor.
For Stat factors, DNA template-dependent synergy with members of the Ets family and C/EBP has been described. In the c-fos gene promoter, Stat1 and Stat3 cooperate with ternary complex factors (42) (47); and the binding of the carboxyl-terminal domain of Stat2 to the p300/CBP transcriptional adaptor (48) .
GR molecules usually utilize palindromic sites for high affinity DNA binding. They are composed of hexameric half-sites with the consensus 5Ј-TGTTCT-3Ј spaced by 3 nucleotides (15) . The GR-binding sites characterized in the lactogenic hormone response elements were non-classical sites. They represent half-palindromic sites (13, 14) . Half-sites binding monomeric GR molecules have been found to be unable to confer glucocorticoid-inducible transcription on a heterologous promoter by themselves (17) . However, in complex glucocorticoid response elements, half-palindromic sites have been mapped which are essential in mediating the effect of glucocorticoid hormones (17, 18) . Functional half-palindromic binding sites were also described for the estrogen receptor in the far upstream estrogen response element of the ovalbumin gene (49) . Mutational analysis of the three proximal GR half-sites in the ␤-casein gene promoter (Fig. 5A) revealed the functional importance of the half-palindromic sites in GRa, GRb, GRc, and GRe. In the lactogenic hormone response element the utilization of halfsites by the GR appears to be one important means for ensuring the stage-specific activation of milk protein expression: here, glucocorticoids are unable to induce transcription via the GR half-sites alone, but require the synergy with Stat5 activated by prolactin. Although the unusual spacing and orientation of GR half-sites in lactogenic hormone response elements would not allow a favorable steric alignment of GRs like the one observed with classical GREs, direct interactions between receptors bound to several sites might be important. In addition, or alternatively, interactions of the GR with other factors binding to neighboring sites could stabilize the binding of the GR to half-palindromes. For the ␤-casein gene a cooperative binding between C/EBP and GR could be important, since several binding sites for C/EBP were mapped vicinal to GR half-palindromic sites (23) . In the case of the whey acidic protein gene promoter, CTF/NF-1 could be involved (10, 14) .
Two cellular systems were employed in the present study. COS-7 cells allowed to assess directly the role of Stat5 in transient cotransfection experiments. However, a drawback of this system is that the cells are not of mammary epithelial origin and the expression levels of Stat5 and GR are very high, giving rise to the question whether the results obtained are relevant for the in vivo regulation of milk protein genes by lactogenic hormones. We thus also used HC11 mammary epithelial cells which can be induced by glucocorticoids and prolactin to express the endogenous ␤-casein gene. It was possible to demonstrate a functional role of GR half-sites in mediating the response of lactogenic hormones in this cell line (Fig. 5B) , suggesting that the mechanism of interaction between GR and Stat5 is the same in HC11 and COS-7 cells and thus of general relevance for the regulation of milk protein gene expression.
In HC11 cells the action of lactogenic hormones on milk protein expression is slow (50) . An indirect effect of glucocorticoids on transcription, mediated by the activation or repression of a gene regulated by the GR has been described to account for the slow response (22) . Our data presented here implicate that, in addition, the GR exerts a direct effect on the lactogenic hormone response element. Regulation of gene expression by direct and indirect mechanisms has also been reported to account for the action of glucocorticoids on the ␣2-uteroglobulin (51) and the ␣-amylase 2 (18) genes, which both contain functional GR half-sites similar as the lactogenic hormone response elements.
Stat5a and Stat5b, which differ significantly in their carboxyl terminus, were equally potent in their cooperativity with the GR (Fig. 6) . Interestingly, Stat5 devoid of the carboxyl terminus was as efficient in mediating the synergism with the GR as full-length Stat5. The deleted region contains the major transactivation domain of Stat5 important for the response to prolactin alone (31) . Thus, the finding implies that either the transcriptional activation in the synergistic response is predominantly mediated by the GR, or that a cryptic transactivation domain of Stat5 is unmasked by the interaction with the GR. Stat5 molecules lacking the carboxyl-terminal transactivation domain have been described as dominant negative (31). They efficiently inhibited the activation of prolactin-dependent genes, presumably because they retained the ability to bind DNA and thereby were able to compete with transcriptionally active, full-length Stat5 molecules. Since, as shown in Fig. 6 , carboxyl-terminally deleted Stat5s are not impaired in their ability to synergize with the GR to activate transcription, these molecules should allow the specific repression of genes regulated by prolactin only, without affecting genes synergistically regulated by both dexamethasone and prolactin. Further mutation and deletion experiments will reveal the domains of Stat5 required for a functional interaction with GR. It will be interesting to see whether other steroid receptors can also interact with Stat5 and whether other members of the Stat family are able to cooperate with the glucocorticoid receptor.
